WEE1 inhibition concomitantly activates STAT1 signaling, increasing IFN-γ and PD-L1 expression, and enhances the efficacy of PD-L1 blockade in SCLC mouse models. This evidence concerns the gene STAT1 and small cell lung carcinoma.